4D Molecular Therapeutics (FDMT) Earnings Date & Reports

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

FDMT is expected to report earnings to fall 3.26% to -86 cents per share on May 08

4D Molecular Therapeutics FDMT Stock Earnings Reports

Q1'25

Est.

$-0.86

Q4'24

Missed

by $0.05

Q3'24

Missed

by $0.11

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.08

The last earnings report on February 28 showed earnings per share of -88 cents, missing the estimate of -84 cents. With 1.09M shares outstanding, the current market capitalization sits at 151.87M.

View a ticker or compare two or three

Compare

FDMT